Black Rock Inc. Alkermes Plc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Alkermes Plc. stock. As of the latest transaction made, Black Rock Inc. holds 29,168,481 shares of ALKS stock, worth $683 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

29,168,481

Previous 30,022,427 2.84%

Holding current value

$683 Million

Previous $833 Million 5.19%

% of portfolio

0.02%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$26.4 - $32.56 $22.5 Million - $27.8 Million	-853,946 Reduced 2.84%	29,168,481 $790 Million
Q4 2023 Feb 13, 2024	BUY	$23.37 - $28.68 $301 Million - $369 Million	12,861,170 Added 74.94%	30,022,427 $833 Million
Q3 2023 Nov 13, 2023	BUY	$27.17 - $31.97 $7.38 Million - $8.69 Million	271,782 Added 1.61%	17,161,257 $481 Million
Q2 2023 Aug 11, 2023	BUY	$28.34 - $33.63 $7.6 Million - $9.02 Million	268,222 Added 1.61%	16,889,475 $529 Million
Q1 2023 May 12, 2023	BUY	$25.31 - $29.02 $4.99 Million - $5.72 Million	197,079 Added 1.2%	16,621,253 $469 Million

Q4 2022 Feb 13, 2023	BUY	$21.94 - $26.24 $20.5 Million - $24.6 Million	935,968 Added 6.04%	16,424,174 $429 Million
Q3 2022 Nov 14, 2022	SELL	$22.0 - $31.87 $6.57 Million - $9.52 Million	-298,654 Reduced 1.89%	15,488,206 $346 Million
Q2 2022 Aug 12, 2022	BUY	$26.4 - $30.54 $18.7 Million - $21.6 Million	706,814 Added 4.69%	15,786,860 $470 Million
Q1 2022 May 12, 2022	BUY	$23.07 - $27.99 $19.1 Million - $23.2 Million	827,759 Added 5.81%	15,080,046 $397 Million
Q4 2021 Feb 10, 2022	BUY	$21.47 - $32.08 $25 Million - $37.3 Million	1,163,567 Added 8.89%	14,252,287 $332 Million
Q3 2021 Nov 09, 2021	BUY	$23.37 - $32.13 $1.22 Million - $1.68 Million	52,174 Added 0.4%	13,088,720 $404 Million
Q2 2021 Aug 11, 2021	BUY	$18.78 - $25.15 $245 Million - $328 Million	13,036,546 New	13,036,546 $320 Million

Others Institutions Holding ALKS

# of Institutions

358

Shares Held

180M

Call Options Held

522K

Put Options Held

463K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $3.84B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account